Judith A Reinsdorf
CIK 1305361 · View on SEC EDGAR ↗
First SEC filing: Jan. 20, 2026 · Latest: Jan. 20, 2026
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 12, 2015 | JCI | S | 116,258 | $37.71 | $4,384,089 | 199,201 Direct | -36.85% | Disposed | 267.3% (price as of 2026-08-21) |
| Aug. 3, 2012 | JCI | S | 113,525 | $55.25 | $6,272,256 | 88,540 Direct | -56.18% | Disposed | 404.3% (price as of 2026-08-21) |
Showing latest 100 of 126 transactions
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 30, 2026 | NPO | Phantom Stock | Common Stock (74) | — | — | 74 | Acquired |
| June 17, 2026 | NPO | Phantom Stock | Common Stock (1) | — | — | 1 | Acquired |
| May 15, 2026 | NRIX | Director Stock Option (right to buy) | Common Stock (31,250) | $15.86 | May 14, 2036 | 31,250 | Acquired |
| March 31, 2026 | NPO | Phantom Stock | Common Stock (112) | — | — | 112 | Acquired |
| March 18, 2026 | NPO | Phantom Stock | Common Stock (1) | — | — | 1 | Acquired |
| Jan. 19, 2026 | TOL | Restricted Stock Units | Common Stock (1,295) | $0.00 | Dec. 19, 2025 | 1,295 | Disposed |
| Dec. 31, 2025 | NPO | Phantom Stock | Common Stock (128) | — | — | 128 | Acquired |
| Dec. 22, 2025 | TOL | Restricted Stock Units | Common Stock (1,423) | $0.00 | Dec. 22, 2026 | 1,423 | Acquired |
| Dec. 17, 2025 | NPO | Phantom Stock | Common Stock (1) | — | — | 1 | Acquired |
| Sept. 30, 2025 | NPO | Phantom Stock | Common Stock (122) | — | — | 122 | Acquired |
| Sept. 17, 2025 | NPO | Phantom Stock | Common Stock (0) | — | — | 0 | Acquired |
| June 30, 2025 | NPO | Phantom Stock | Common Stock (144) | — | — | 144 | Acquired |
| June 18, 2025 | NPO | Phantom Stock | Common Stock (0) | — | — | 0 | Acquired |
| March 31, 2025 | NPO | Phantom Stock | Common Stock (170) | — | — | 170 | Acquired |
| Dec. 19, 2024 | TOL | Restricted Stock Units | Common Stock (1,295) | $0.00 | Dec. 19, 2025 | 1,295 | Acquired |
| May 4, 2023 | NRIX | Director Stock Option (right to buy) | Common Stock (25,000) | $9.44 | May 3, 2033 | 25,000 | Acquired |
| Sept. 14, 2022 | NPO | Phantom Stock | Common Stock (1) | — | — | 1 | Acquired |
| June 15, 2022 | NPO | Phantom Stock | Common Stock (1) | — | — | 1 | Acquired |
| May 5, 2022 | NRIX | Director Stock Option (right to buy) | Common Stock (17,500) | $10.39 | May 4, 2032 | 17,500 | Acquired |
| March 16, 2022 | NPO | Phantom Stock | Common Stock (1) | — | — | 1 | Acquired |
| Dec. 15, 2021 | NPO | Phantom Stock | Common Stock (1) | — | — | 1 | Acquired |
| Oct. 1, 2021 | NRIX | Director Stock Option (right to buy) | Common Stock (35,000) | $31.24 | Sept. 30, 2031 | 35,000 | Acquired |
| Sept. 15, 2021 | NPO | Phantom Stock | Common Stock (1) | — | — | 1 | Acquired |
| Sept. 1, 2021 | NPO | Phantom Stock | Common Stock (427) | — | — | 427 | Acquired |
| Oct. 7, 2016 | JCI | Employee Stock Option (Right to Buy) | Ordinary Shares (55,617) | $45.29 | Oct. 7, 2026 | 55,617 | Acquired |
| Oct. 12, 2015 | JCI | Stock Option (Right to Buy) | Common Shares (78,442) | $36.08 | Oct. 11, 2025 | 78,442 | Acquired |
| Aug. 12, 2015 | JCI | Stock Option (Right to Buy) | Common Shares (24,620) | $14.33 | Oct. 6, 2018 | 24,620 | Disposed |
| Aug. 12, 2015 | JCI | Stock Option (Right to Buy) | Common Shares (46,990) | $26.37 | July 1, 2017 | 46,990 | Disposed |
| Aug. 12, 2015 | JCI | Stock Option (Right to Buy) | Common Shares (44,648) | $25.27 | May 9, 2017 | 44,648 | Disposed |
| Nov. 25, 2014 | JCI | Stock Option (Right to Buy) | Common Shares (51,226) | $43.38 | Nov. 24, 2024 | 51,226 | Acquired |
| Sept. 26, 2014 | JCI | Performance Share Units | Common Shares (65,422) | — | — | 65,422 | Disposed |
| Nov. 20, 2013 | JCI | Stock Option (Right to Buy) | Common Shares (59,817) | $37.15 | Nov. 19, 2023 | 59,817 | Acquired |
| Sept. 27, 2013 | JCI | Performance Share Units | Common Shares (34,843) | — | — | 34,843 | Disposed |
| Nov. 20, 2012 | JCI | Stock Option (Right to Buy) | Common Shares (51,100) | $27.14 | Nov. 19, 2022 | 51,100 | Acquired |
| Nov. 20, 2012 | JCI | Stock Option (Right to Buy) | Common Shares (81,800) | $27.14 | Nov. 19, 2022 | 81,800 | Acquired |
| Sept. 28, 2012 | JCI | Performance Share Units | Common Shares (22,200) | — | — | 22,200 | Disposed |
| Aug. 3, 2012 | JCI | Stock Option (Right to Buy) | Common Shares (39,650) | $33.75 | Sept. 30, 2019 | 39,650 | Disposed |
| Aug. 3, 2012 | JCI | Stock Option (Right to Buy) | Common Shares (73,875) | $29.00 | — | 73,875 | Disposed |
| Oct. 12, 2011 | JCI | Stock Option (Right to Buy) | Common Shares (56,800) | $44.32 | Oct. 11, 2021 | 56,800 | Acquired |
| Oct. 12, 2011 | JCI | Performance Share Units | Common Shares (27,500) | — | — | 27,500 | Disposed |
| Oct. 12, 2011 | JCI | Performance Share Units | Common Shares (15,300) | — | — | 15,300 | Acquired |
| July 2, 2011 | JCI | Restricted Stock Units | Common Shares (5,377) | — | — | 5,377 | Disposed |
| Oct. 12, 2010 | JCI | Stock Option (Right to Buy) | Common Shares (67,500) | $37.29 | Oct. 11, 2020 | 67,500 | Acquired |
| Oct. 12, 2010 | JCI | Performance Share Units | Common Shares (18,200) | — | — | 18,200 | Acquired |
| July 2, 2010 | JCI | Restricted Stock Units | Common Shares (5,260) | — | — | 5,260 | Disposed |
| Oct. 1, 2009 | JCI | Stock Option (Right to Buy) | Common Shares (79,300) | $33.75 | Sept. 30, 2019 | 79,300 | Acquired |
| Oct. 1, 2009 | JCI | Performance Share Units | Common Shares (22,200) | — | — | 22,200 | Acquired |
| July 2, 2009 | JCI | Restricted Stock Units | Common Shares (5,133) | — | — | 5,133 | Disposed |
| May 10, 2009 | JCI | Restricted Stock Units | Common Shares (23,123) | — | — | 23,123 | Disposed |
| Oct. 7, 2008 | JCI | Stock Option (Right to Buy) | Common Shares (98,500) | $29.00 | — | 98,500 | Acquired |
| Oct. 7, 2008 | JCI | Performance Share Units | Common Shares (27,500) | — | — | 27,500 | Acquired |
| May 9, 2008 | JCI | Restricted Stock Units [F1] | Common Shares (22,635) | — | — | 22,635 | Disposed |
| May 9, 2008 | JCI | Restricted Stock Units | Common Shares (8,073) | — | — | 8,073 | Disposed |
| July 2, 2007 | JCI | Stock Option (Right to Buy) | Common Shares (47,000) | $53.36 | July 1, 2017 | 47,000 | Acquired |
| July 2, 2007 | JCI | Performance Share Units | Common Shares (14,800) | — | — | 14,800 | Acquired |
| July 2, 2007 | JCI | Restricted Stock Units | Common Shares (14,800) | — | — | 14,800 | Acquired |
| June 29, 2007 | JCI | Stock Option (Right to Buy) | Common Shares (44,657) | $51.14 | May 9, 2017 | 44,657 | Acquired |
| June 29, 2007 | JCI | Restricted Stock Units | Common Shares (44,791) | — | — | 44,791 | Acquired |
| May 10, 2007 | JCI | Stock Option (Right to Buy) | Common Shares (70,945) | $32.19 | May 9, 2017 | 70,945 | Acquired |
| May 10, 2007 | JCI | Stock Option (Right to Buy) | Common Shares (22,702) | $32.19 | May 9, 2017 | 22,702 | Acquired |
| May 10, 2007 | JCI | Restricted Stock Units | Common Shares (70,945) | — | — | 70,945 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
JCI
General Counsel| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2014 | $535,000 | — | — | $646,622 | $449,400 | — | $111,286 | $2,672,306 |
| 2013 | $535,000 | — | — | $999,368 | $449,400 | — | $106,434 | $3,434,230 |
| 2012 | $535,000 | $200,000 | — | $746,233 | $393,760 | — | $134,974 | $3,891,771 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.